Effect of the infusion of pGlu-His-D-Ala-OH on pancreatic secretion in obese subjects

A. L. Calle-Pascual, C. Rodriguez, E. Yuste, J. M. De Matias, A. L. Charro, I. Carretero, B. Garcia, R. Z. Cai, Andrew V Schally

Research output: Contribution to journalArticle

Abstract

The effects of intravenous infusion of pGlu-His-D-Ala-OH, an analog of the postulated anorexigenic peptide pGlu-His-Gly-OH, on the pancreatic response to the oral ingestion of 75 g of glucose were evaluated in 6 obese subjects. The infusion of the analog significantly reduced the serum insulin response to the oral ingestion of glucose (p < 0.05), but did not modify the levels of C-peptide, gastrin, glucose or serum amylases. Similarly, the area under the curve, which represents the insulin response to the oral ingestion of glucose was reduced from 35,303 ± 7,061 to 20,590 ± 2,286 pmol/min/l; p < 0.05. The smaller rise in serum insulin was associated with a greater hepatic insulin extraction, measured in terms of the molar ratio of the C-peptide to insulin, from 76.06 ± 2.4% vs 88.62 ± 1.71%; p < 0.05. However, there was no decrease in the pancreatic insulin secretion, measured as the C-peptide levels. These results demonstrate that the infusion of the anorexigenic peptide analog improves hepatic insulin extraction in obese subjects. Its therapeutic application in obesity remains to be determined.

Original languageEnglish
Pages (from-to)129-133
Number of pages5
JournalDiabetes, Nutrition and Metabolism - Clinical and Experimental
Volume4
Issue number2
StatePublished - Jul 31 1991
Externally publishedYes

Fingerprint

insulin
secretion
Insulin
peptides
C-Peptide
mouth
glucose
Glucose
ingestion
Eating
Serum
gastrins
liver
insulin secretion
amylases
Liver
Gastrins
Amylases
pyroglutamyl-histidyl-alanine
Intravenous Infusions

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Internal Medicine
  • Endocrinology
  • Food Science
  • Endocrinology, Diabetes and Metabolism

Cite this

Calle-Pascual, A. L., Rodriguez, C., Yuste, E., De Matias, J. M., Charro, A. L., Carretero, I., ... Schally, A. V. (1991). Effect of the infusion of pGlu-His-D-Ala-OH on pancreatic secretion in obese subjects. Diabetes, Nutrition and Metabolism - Clinical and Experimental, 4(2), 129-133.

Effect of the infusion of pGlu-His-D-Ala-OH on pancreatic secretion in obese subjects. / Calle-Pascual, A. L.; Rodriguez, C.; Yuste, E.; De Matias, J. M.; Charro, A. L.; Carretero, I.; Garcia, B.; Cai, R. Z.; Schally, Andrew V.

In: Diabetes, Nutrition and Metabolism - Clinical and Experimental, Vol. 4, No. 2, 31.07.1991, p. 129-133.

Research output: Contribution to journalArticle

Calle-Pascual, AL, Rodriguez, C, Yuste, E, De Matias, JM, Charro, AL, Carretero, I, Garcia, B, Cai, RZ & Schally, AV 1991, 'Effect of the infusion of pGlu-His-D-Ala-OH on pancreatic secretion in obese subjects', Diabetes, Nutrition and Metabolism - Clinical and Experimental, vol. 4, no. 2, pp. 129-133.
Calle-Pascual AL, Rodriguez C, Yuste E, De Matias JM, Charro AL, Carretero I et al. Effect of the infusion of pGlu-His-D-Ala-OH on pancreatic secretion in obese subjects. Diabetes, Nutrition and Metabolism - Clinical and Experimental. 1991 Jul 31;4(2):129-133.
Calle-Pascual, A. L. ; Rodriguez, C. ; Yuste, E. ; De Matias, J. M. ; Charro, A. L. ; Carretero, I. ; Garcia, B. ; Cai, R. Z. ; Schally, Andrew V. / Effect of the infusion of pGlu-His-D-Ala-OH on pancreatic secretion in obese subjects. In: Diabetes, Nutrition and Metabolism - Clinical and Experimental. 1991 ; Vol. 4, No. 2. pp. 129-133.
@article{62e3d120be764e8aa04e53cae1f9d2e2,
title = "Effect of the infusion of pGlu-His-D-Ala-OH on pancreatic secretion in obese subjects",
abstract = "The effects of intravenous infusion of pGlu-His-D-Ala-OH, an analog of the postulated anorexigenic peptide pGlu-His-Gly-OH, on the pancreatic response to the oral ingestion of 75 g of glucose were evaluated in 6 obese subjects. The infusion of the analog significantly reduced the serum insulin response to the oral ingestion of glucose (p < 0.05), but did not modify the levels of C-peptide, gastrin, glucose or serum amylases. Similarly, the area under the curve, which represents the insulin response to the oral ingestion of glucose was reduced from 35,303 ± 7,061 to 20,590 ± 2,286 pmol/min/l; p < 0.05. The smaller rise in serum insulin was associated with a greater hepatic insulin extraction, measured in terms of the molar ratio of the C-peptide to insulin, from 76.06 ± 2.4{\%} vs 88.62 ± 1.71{\%}; p < 0.05. However, there was no decrease in the pancreatic insulin secretion, measured as the C-peptide levels. These results demonstrate that the infusion of the anorexigenic peptide analog improves hepatic insulin extraction in obese subjects. Its therapeutic application in obesity remains to be determined.",
author = "Calle-Pascual, {A. L.} and C. Rodriguez and E. Yuste and {De Matias}, {J. M.} and Charro, {A. L.} and I. Carretero and B. Garcia and Cai, {R. Z.} and Schally, {Andrew V}",
year = "1991",
month = "7",
day = "31",
language = "English",
volume = "4",
pages = "129--133",
journal = "Diabetes, Nutrition and Metabolism - Clinical and Experimental",
issn = "0394-3402",
publisher = "Editrice Kurtis s.r.l.",
number = "2",

}

TY - JOUR

T1 - Effect of the infusion of pGlu-His-D-Ala-OH on pancreatic secretion in obese subjects

AU - Calle-Pascual, A. L.

AU - Rodriguez, C.

AU - Yuste, E.

AU - De Matias, J. M.

AU - Charro, A. L.

AU - Carretero, I.

AU - Garcia, B.

AU - Cai, R. Z.

AU - Schally, Andrew V

PY - 1991/7/31

Y1 - 1991/7/31

N2 - The effects of intravenous infusion of pGlu-His-D-Ala-OH, an analog of the postulated anorexigenic peptide pGlu-His-Gly-OH, on the pancreatic response to the oral ingestion of 75 g of glucose were evaluated in 6 obese subjects. The infusion of the analog significantly reduced the serum insulin response to the oral ingestion of glucose (p < 0.05), but did not modify the levels of C-peptide, gastrin, glucose or serum amylases. Similarly, the area under the curve, which represents the insulin response to the oral ingestion of glucose was reduced from 35,303 ± 7,061 to 20,590 ± 2,286 pmol/min/l; p < 0.05. The smaller rise in serum insulin was associated with a greater hepatic insulin extraction, measured in terms of the molar ratio of the C-peptide to insulin, from 76.06 ± 2.4% vs 88.62 ± 1.71%; p < 0.05. However, there was no decrease in the pancreatic insulin secretion, measured as the C-peptide levels. These results demonstrate that the infusion of the anorexigenic peptide analog improves hepatic insulin extraction in obese subjects. Its therapeutic application in obesity remains to be determined.

AB - The effects of intravenous infusion of pGlu-His-D-Ala-OH, an analog of the postulated anorexigenic peptide pGlu-His-Gly-OH, on the pancreatic response to the oral ingestion of 75 g of glucose were evaluated in 6 obese subjects. The infusion of the analog significantly reduced the serum insulin response to the oral ingestion of glucose (p < 0.05), but did not modify the levels of C-peptide, gastrin, glucose or serum amylases. Similarly, the area under the curve, which represents the insulin response to the oral ingestion of glucose was reduced from 35,303 ± 7,061 to 20,590 ± 2,286 pmol/min/l; p < 0.05. The smaller rise in serum insulin was associated with a greater hepatic insulin extraction, measured in terms of the molar ratio of the C-peptide to insulin, from 76.06 ± 2.4% vs 88.62 ± 1.71%; p < 0.05. However, there was no decrease in the pancreatic insulin secretion, measured as the C-peptide levels. These results demonstrate that the infusion of the anorexigenic peptide analog improves hepatic insulin extraction in obese subjects. Its therapeutic application in obesity remains to be determined.

UR - http://www.scopus.com/inward/record.url?scp=0025908567&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025908567&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0025908567

VL - 4

SP - 129

EP - 133

JO - Diabetes, Nutrition and Metabolism - Clinical and Experimental

JF - Diabetes, Nutrition and Metabolism - Clinical and Experimental

SN - 0394-3402

IS - 2

ER -